• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向线粒体通透性转换孔的开放可增强纳米颗粒药物递送并减轻癌症转移。

Targeting the Opening of Mitochondrial Permeability Transition Pores Potentiates Nanoparticle Drug Delivery and Mitigates Cancer Metastasis.

作者信息

Lin Xi, Li Lian, Li Shujie, Li Qiuyi, Xie Dandan, Zhou Minglu, Huang Yuan

机构信息

Key Laboratory of Drug Targeting and Drug Delivery System (Ministry of Education) West China School of Pharmacy Sichuan University No. 17, Block 3, South Renmin Road Chengdu 610041 P.R. China.

出版信息

Adv Sci (Weinh). 2020 Dec 31;8(4):2002834. doi: 10.1002/advs.202002834. eCollection 2021 Feb.

DOI:10.1002/advs.202002834
PMID:33643797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7887600/
Abstract

Mitochondria are highly involved in the metastasis of cancer cells. However, low permeability of mitochondria impedes the entry of anti-cancer drugs. Here, a self-assembled nanoparticle platform is designed that not only targets the DNA-intercalating agent doxorubicin to mitochondria but also enhances the specific penetration by opening the mitochondrial permeability transition pores (MPTPs). With drastic improvement in mitochondrial uptake, the drug delivery system results in substantial mitochondrial impairment leading to amplified induction of apoptosis, depletion of energy supply, and inhibition of numerous metastasis-associated proteins. As a consequence, the drug delivery system significantly inhibits the orthotopic tumor growth, and suppressed the metastasis of cancer cells detached from primary tumors. Additionally, the nanoparticle exhibits a potent effect on eradicating the metastasis of disseminated tumor cell from blood to lung. The results show that strategies of targeting mitochondria and unlocking MPTP are feasible and beneficial to mitigate both tumorigenesis and metastasis.

摘要

线粒体在癌细胞转移过程中发挥着重要作用。然而,线粒体的低通透性阻碍了抗癌药物的进入。在此,设计了一种自组装纳米颗粒平台,它不仅能将DNA嵌入剂阿霉素靶向输送到线粒体,还能通过打开线粒体通透性转换孔(MPTP)增强特异性渗透。随着线粒体摄取的显著改善,该药物递送系统导致线粒体严重受损,进而放大了细胞凋亡的诱导、能量供应的消耗以及对多种转移相关蛋白的抑制。因此,该药物递送系统显著抑制原位肿瘤生长,并抑制原发肿瘤脱落癌细胞的转移。此外,纳米颗粒对消除从血液转移至肺部的播散肿瘤细胞的转移具有显著效果。结果表明,靶向线粒体和开启MPTP的策略对于减轻肿瘤发生和转移是可行且有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/c55b8e16ecac/ADVS-8-2002834-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/435410259dbd/ADVS-8-2002834-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/2170d4affac3/ADVS-8-2002834-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/6f06807d205b/ADVS-8-2002834-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/924e1f150544/ADVS-8-2002834-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/f4de31437c43/ADVS-8-2002834-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/7fc9f6197e16/ADVS-8-2002834-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/c55b8e16ecac/ADVS-8-2002834-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/435410259dbd/ADVS-8-2002834-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/2170d4affac3/ADVS-8-2002834-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/6f06807d205b/ADVS-8-2002834-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/924e1f150544/ADVS-8-2002834-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/f4de31437c43/ADVS-8-2002834-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/7fc9f6197e16/ADVS-8-2002834-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e440/7887600/c55b8e16ecac/ADVS-8-2002834-g007.jpg

相似文献

1
Targeting the Opening of Mitochondrial Permeability Transition Pores Potentiates Nanoparticle Drug Delivery and Mitigates Cancer Metastasis.靶向线粒体通透性转换孔的开放可增强纳米颗粒药物递送并减轻癌症转移。
Adv Sci (Weinh). 2020 Dec 31;8(4):2002834. doi: 10.1002/advs.202002834. eCollection 2021 Feb.
2
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin.铁和阿霉素激活的线粒体通透性转换孔的保护因子
Curr Cancer Drug Targets. 2021;21(6):514-525. doi: 10.2174/1568009621999210120192558.
3
A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.一种苯并吡咯烷衍生物揭示了心肌线粒体通透性转换孔的双重抑制机制,但其心肌分布限制了其作用。
J Pharmacol Exp Ther. 2021 Mar;376(3):348-357. doi: 10.1124/jpet.120.000359. Epub 2020 Dec 10.
4
Combination of mitochondria targeting doxorubicin with Bcl-2 function-converting peptide NuBCP-9 for synergistic breast cancer metastasis inhibition.线粒体靶向阿霉素与 Bcl-2 功能转换肽 NuBCP-9 联合抑制协同乳腺癌转移。
J Mater Chem B. 2021 Feb 7;9(5):1336-1350. doi: 10.1039/d0tb02564j. Epub 2021 Jan 14.
5
Opening of mitochondrial permeability transition pore in cardiomyocytes: Is ferutinin a suitable tool for its assessment?心肌细胞中线粒体通透性转换孔的开放: ferutinin 是否适合用于评估?
Fundam Clin Pharmacol. 2023 Aug;37(4):739-752. doi: 10.1111/fcp.12879. Epub 2023 Feb 26.
6
Mitochondrial permeability regulates cardiac endothelial cell necroptosis and cardiac allograft rejection.线粒体通透性调节心脏内皮细胞坏死性凋亡和心脏同种异体移植排斥反应。
Am J Transplant. 2019 Mar;19(3):686-698. doi: 10.1111/ajt.15112. Epub 2018 Oct 16.
7
Concurrent impairment of nucleus and mitochondria for synergistic inhibition of cancer metastasis.协同抑制癌症转移的核和线粒体同时损伤。
Int J Pharm. 2021 Oct 25;608:121077. doi: 10.1016/j.ijpharm.2021.121077. Epub 2021 Sep 4.
8
Cyclophilin D-mediated Mitochondrial Permeability Transition Regulates Mitochondrial Function.亲环素 D 介导线粒体通透性转换调节线粒体功能。
Curr Pharm Des. 2023;29(8):620-629. doi: 10.2174/1381612829666230313111314.
9
Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.抑制Bcl-2可使缺血损伤线粒体中的线粒体通透性转换孔(MPTP)开放更加敏感。
PLoS One. 2015 Mar 10;10(3):e0118834. doi: 10.1371/journal.pone.0118834. eCollection 2015.
10
Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening.瑞滨通过抑制能量代谢和诱导线粒体通透性转换孔开放逆转 SMMC-7721 肝癌细胞多柔比星耐药性。
Biofactors. 2019 Jan;45(1):85-96. doi: 10.1002/biof.1462. Epub 2018 Nov 29.

引用本文的文献

1
Targeting FCRLA to induce necrosis in lung adenocarcinoma: a novel strategy for prognosis and therapy via MPT-Driven pathways.靶向FCRLA诱导肺腺癌坏死:通过线粒体通透性转换驱动途径进行预后和治疗的新策略。
Front Immunol. 2025 Aug 13;16:1596179. doi: 10.3389/fimmu.2025.1596179. eCollection 2025.
2
Mitochondria-Targeted Cassic Acid Base Nanoprodrug for Enhanced Anti-Inflammatory and Osteogenic Effects in Osteoarthritis.用于增强骨关节炎抗炎和成骨作用的线粒体靶向肉桂酸基纳米前药
ACS Omega. 2025 Aug 11;10(32):35940-35953. doi: 10.1021/acsomega.5c03216. eCollection 2025 Aug 19.
3
Emerging magic bullet: subcellular organelle-targeted cancer therapy.

本文引用的文献

1
Inhibition of Immunosuppressive Tumors by Polymer-Assisted Inductions of Immunogenic Cell Death and Multivalent PD-L1 Crosslinking.通过聚合物辅助诱导免疫原性细胞死亡和多价PD-L1交联抑制免疫抑制性肿瘤
Adv Funct Mater. 2020 Mar 17;30(12). doi: 10.1002/adfm.201908961. Epub 2020 Feb 3.
2
Photoactivatable Protherapeutic Nanomedicine for Cancer.光激活型治疗性纳米医学用于癌症治疗。
Adv Mater. 2020 Aug;32(34):e2002661. doi: 10.1002/adma.202002661. Epub 2020 Jul 15.
3
Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments.
新兴的神奇子弹:亚细胞器靶向癌症治疗
Med Rev (2021). 2024 Sep 12;5(2):117-138. doi: 10.1515/mr-2024-0044. eCollection 2025 Apr.
4
Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway.黄芪多酚通过激活PI3K/AKT/NRF2信号通路减轻阿霉素诱导的心脏毒性。
PLoS One. 2025 Feb 25;20(2):e0319067. doi: 10.1371/journal.pone.0319067. eCollection 2025.
5
A rhodamine-coordinated iridium complex to overcome cisplatin-resistant cancer via regulating mitochondrial function triggered apoptosis and ferroptosis.一种罗丹明配位的铱配合物通过调节线粒体功能触发细胞凋亡和铁死亡来克服顺铂耐药性癌症。
Redox Biol. 2025 Apr;81:103536. doi: 10.1016/j.redox.2025.103536. Epub 2025 Feb 10.
6
Mitochondria-Targeting Virus-Like Gold Nanoparticles Enhance Chemophototherapeutic Efficacy Against Pancreatic Cancer in a Xenograft Mouse Model.线粒体靶向病毒样金纳米颗粒增强异种移植小鼠模型中对胰腺癌的化学光热治疗效果。
Int J Nanomedicine. 2024 Dec 28;19:14059-14074. doi: 10.2147/IJN.S497346. eCollection 2024.
7
Photoactivated hydride therapy under hypoxia beyond ROS.缺氧条件下超越活性氧的光激活氢化物疗法
Chem Sci. 2024 Nov 12;15(48):20292-20302. doi: 10.1039/d4sc06576j. eCollection 2024 Dec 11.
8
Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy.线粒体代谢阻断纳米佐剂逆转免疫抵抗微环境,使基于白蛋白结合型紫杉醇的化学免疫疗法敏感化。
Acta Pharm Sin B. 2024 Sep;14(9):4087-4101. doi: 10.1016/j.apsb.2024.05.028. Epub 2024 Jun 3.
9
Biodegradable copper-iodide clusters modulate mitochondrial function and suppress tumor growth under ultralow-dose X-ray irradiation.可生物降解的碘化铜簇在超低剂量X射线照射下调节线粒体功能并抑制肿瘤生长。
Nat Commun. 2024 Sep 16;15(1):8092. doi: 10.1038/s41467-024-52278-6.
10
Nano-flow cytometry unveils mitochondrial permeability transition process and multi-pathway cell death induction for cancer therapy.纳米流式细胞术揭示线粒体通透性转换过程及癌症治疗中多途径细胞死亡诱导机制。
Cell Death Discov. 2024 Apr 15;10(1):176. doi: 10.1038/s41420-024-01947-y.
联合磁热疗和免疫疗法治疗原发性和转移性肿瘤。
ACS Nano. 2020 Jan 28;14(1):1033-1044. doi: 10.1021/acsnano.9b08550. Epub 2020 Jan 16.
4
Eradication of unresectable liver metastasis through induction of tumour specific energy depletion.通过诱导肿瘤特异性能量耗竭来根除不可切除的肝转移。
Nat Commun. 2019 Jul 11;10(1):3051. doi: 10.1038/s41467-019-11082-3.
5
Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy.有机半导体前纳米刺激剂用于近红外光激活的癌症免疫治疗。
Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12680-12687. doi: 10.1002/anie.201906288. Epub 2019 Jul 30.
6
An Organic Afterglow Protheranostic Nanoassembly.一种有机余辉型诊疗一体化纳米组装体。
Adv Mater. 2019 Aug;31(32):e1902672. doi: 10.1002/adma.201902672. Epub 2019 Jun 17.
7
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.靶向线粒体的 Lonidamine 可减轻肺肿瘤发生和脑转移。
Nat Commun. 2019 May 17;10(1):2205. doi: 10.1038/s41467-019-10042-1.
8
Organic Photodynamic Nanoinhibitor for Synergistic Cancer Therapy.有机光动力纳米抑制剂协同癌症治疗
Angew Chem Int Ed Engl. 2019 Jun 11;58(24):8161-8165. doi: 10.1002/anie.201903968. Epub 2019 May 9.
9
A Semiconducting Polymer Nano-prodrug for Hypoxia-Activated Photodynamic Cancer Therapy.一种用于缺氧激活光动力癌症治疗的半导体聚合物前药。
Angew Chem Int Ed Engl. 2019 Apr 23;58(18):5920-5924. doi: 10.1002/anie.201814730. Epub 2019 Mar 26.
10
Photoactivatable Organic Semiconducting Pro-nanoenzymes.光激活型有机半导体原纳米酶。
J Am Chem Soc. 2019 Mar 6;141(9):4073-4079. doi: 10.1021/jacs.8b13507. Epub 2019 Feb 20.